Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Arkansas Healthcare Report.
Press releases published on December 15, 2025
December 15, 2025
Waggoner Diagnostics Announces Global Adoption of the Waggoner CCVT Across More Than 80 Countries
Indeterminate
EIN Presswire
December 15, 2025
Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis
Indeterminate
GlobeNewswire
December 15, 2025
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST
Indeterminate
GlobeNewswire
December 15, 2025
XOMA Royalty Enters into Agreement to Acquire Generation Bio
Indeterminate
GlobeNewswire
December 15, 2025
Cellectis Announces Arbitral Decision in Dispute with Servier
Indeterminate
GlobeNewswire
December 15, 2025
Cellectis annonce la décision du tribunal arbitral dans le litige l’opposant à Servier
Indeterminate
GlobeNewswire
December 15, 2025
BioSyent Announces Renewal of Normal Course Issuer Bid
Indeterminate
GlobeNewswire
December 15, 2025
Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain
Indeterminate
GlobeNewswire
December 15, 2025
Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
December 15, 2025
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
Indeterminate
GlobeNewswire
December 15, 2025
Abivax Presents Third Quarter 2025 Financial Results
Indeterminate
GlobeNewswire
December 15, 2025
AEON Biopharma Announces Execution of Exchange Agreement with Daewoong
Indeterminate
GlobeNewswire
December 15, 2025
Madrigal Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
Indeterminate
GlobeNewswire
December 15, 2025
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications
Indeterminate
GlobeNewswire
December 15, 2025
Monte Rosa Therapeutics to Present Updated MRT-2359 Phase 1/2 Study Results
Indeterminate
GlobeNewswire
December 15, 2025
Kyverna Therapeutics Announces Proposed Public Offering of Common Stock
Indeterminate
GlobeNewswire
December 15, 2025
FHSU’s Hybrid BSN Program expands access to nursing education
Indeterminate
GlobeNewswire
December 15, 2025
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
Indeterminate
GlobeNewswire
December 15, 2025
Spero Clinic Delivers Breakthrough: Life-Changing Remission from CRPS
Indeterminate
EIN Presswire